15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Intensive Care Med. 2020 Jul;46(7):1472-1474. doi: 10.1007/s00134-020-06047-w. Epub 2020 Apr 23.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Betacoronavirus*
  • COVID-19
  • China / epidemiology
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality*
  • Critical Illness
  • Drug Therapy, Combination
  • Glucocorticoids / therapeutic use
  • Hospital Mortality*
  • Humans
  • Lorazepam / analogs & derivatives
  • Lorazepam / therapeutic use
  • Lymphopenia / etiology
  • Middle Aged
  • Multiple Organ Failure / etiology
  • Pandemics*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / mortality*
  • Proportional Hazards Models
  • Risk Factors
  • Ritonavir / therapeutic use
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • lopirazepam
  • Lorazepam
  • Ritonavir